Barely Significant

Excerpts

514,629 sentences

borderline significancep = 0.051.0× alpha
cured CE We found higher OPR/LBR (OR 5.33, 95% CI 2.41–11.79, I 2 = 0%, p < 0.0001) and CPR (OR 3.64, 95% CI 1.89–7.04, I 2 = 0%, p = 0.0001) in patients with cured CE in comparison to those with untreated/persistent CE (data from four studies [ 4 , 8 , 12 , 34 ]), with borderline significance in terms of MR ( p = 0.05) ( Figure 3 a–c).
an increasing trendp < 0.051.0× alphagold
marginally significantp = 0.0631.3× alphagold
After mental fatigue inducement, in the theta band, the interaction effect on average path length was significant ( F (3,56) = 3.239, p = 0.029, η p 2 = 0.148) and decreased significantly in the 15 Hz binaural beats group ( p < 0.05); the interaction effect on nodal efficiency was marginally significant ( F (3,56) = 2.568, p = 0.063, η p 2 = 0.121) and the 15 Hz binaural beats group showed an increasing trend ( p < 0.05).
highly significantp < 0.051.0× alphaqualifiedgold
Compared to the control diet group, Kruskal–Willis post hoc analysis demonstrated that groupers fed dietary oleic acid and stearic acid formulations were highly significant ( p < 0.05) compared to the control formulation diet in the post-bacterial challenge.
showed a trendp < 0.051.0× alpha
Given that sample diversities were significantly different between the D0 and D+ samples ( p < 0.05), diversities for all indices were different by blood culture result (sterile or below/above threshold; p < 0.05) and by positivity of a blood culture sample ( p < 0.05, except for Unifrac parameters, which only showed a trend) ( Figure 2 ). 2.3.
approached significancep = .051.0× alpha
However, there was a significant positive correlation between problematic use and a self‐reported measure of anxiety symptoms ( p < .05), while the positive correlation between problematic use and self‐reported depression symptoms approached significance ( p = .05) (Gansner et al., 2020 ).
approaching significancep = 0.0501.0× alphagold
In a sub-analysis of patients with portal vein invasion, OS was 6.5 months (95% CI = 4.5–8.4) in the sorafenib monotherapy group, versus 11.4 months (95% CI = 7.0–15.9) in the sorafenib + low-dose FP combination therapy group, with the difference approaching significance (HR = 0.493, 95% CI = 0.240–1.014, p = 0.050), suggesting that HAIC has an additional effect on OS in patients with major portal vein invasion.
Similar to the result of total complications, bleeding-related complication rates were found to be lower with use of VCD compared with MC in cardiac interventional procedures, but did not reach statistical significance (RR: 0.77, random-effect model, 95% CI, 0.60 to 1.00, p = 0.05; Figure 5(c) ).